These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

758 related items for PubMed ID: 18580561

  • 1. Use of the Neuro-Wrap system for severe post-electroconvulsive therapy headaches.
    Kramer BA, Kadar AG, Clark K.
    J ECT; 2008 Jun; 24(2):152-5. PubMed ID: 18580561
    [Abstract] [Full Text] [Related]

  • 2. Cryotherapy for treatment of ECT-induced headache.
    Drew BI, King ML, Callahan L.
    J Psychosoc Nurs Ment Health Serv; 2005 Apr; 43(4):32-9. PubMed ID: 15884476
    [Abstract] [Full Text] [Related]

  • 3. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M, Jurgens A, Lôo H, Olié JP, Amado I.
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [Abstract] [Full Text] [Related]

  • 4. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP, Cady RK.
    Clin Ther; 2007 Oct; 29 Suppl():2511-9. PubMed ID: 18164918
    [Abstract] [Full Text] [Related]

  • 5. The course of myalgia and headache after electroconvulsive therapy.
    Dinwiddie SH, Huo D, Gottlieb O.
    J ECT; 2010 Jun; 26(2):116-20. PubMed ID: 19710619
    [Abstract] [Full Text] [Related]

  • 6. Sumatriptan for post-ECT headache.
    Fantz RM, Markowitz JS, Kellner CH.
    J ECT; 1998 Dec; 14(4):272-4. PubMed ID: 9871850
    [Abstract] [Full Text] [Related]

  • 7. Intranasal sumatriptan in post-ECT headache: results of an open-label trial.
    Markowitz JS, Kellner CH, DeVane CL, Beale MD, Folk J, Burns C, Liston HL.
    J ECT; 2001 Dec; 17(4):280-3. PubMed ID: 11731730
    [Abstract] [Full Text] [Related]

  • 8. Treatment of primary headache disorders with intravenous valproate: initial outpatient experience.
    Stillman MJ, Zajac D, Rybicki LA.
    Headache; 2004 Jan; 44(1):65-9. PubMed ID: 14979885
    [Abstract] [Full Text] [Related]

  • 9. Electroconvulsive therapy: an effective therapy of medication-resistant bipolar disorder.
    Sienaert P, Peuskens J.
    Bipolar Disord; 2006 Jun; 8(3):304-6. PubMed ID: 16696836
    [Abstract] [Full Text] [Related]

  • 10. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K, Awata S, Takano T, Ebina Y, Iwasaki H, Matsuoka H.
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
    [Abstract] [Full Text] [Related]

  • 11. [Appraisal of treatment of the trigger points associated with relaxation to treat chronic headache in the adult. Relationship with anxiety and stress adaptation strategies].
    Goffaux-Dogniez C, Vanfraechem-Raway R, Verbanck P.
    Encephale; 2003 Aug; 29(5):377-90. PubMed ID: 14615687
    [Abstract] [Full Text] [Related]

  • 12. Headache treatment after electroconvulsive treatment: a single-blinded trial comparator between eletriptan and paracetamol.
    Kertesz DP, Trabekin O, Vanetik MS.
    J ECT; 2015 Jun; 31(2):105-9. PubMed ID: 25181019
    [Abstract] [Full Text] [Related]

  • 13. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.
    Odeberg H, Rodriguez-Silva B, Salander P, Mårtensson B.
    J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624
    [Abstract] [Full Text] [Related]

  • 14. The use of electroconvulsive therapy in the elderly: a study from the psychiatric unit of a north Indian teaching hospital.
    Jain G, Kumar V, Chakrabarti S, Grover S.
    J ECT; 2008 Jun; 24(2):122-7. PubMed ID: 18580554
    [Abstract] [Full Text] [Related]

  • 15. Safety of electroconvulsive therapy in patients with asthma.
    Mueller PS, Schak KM, Barnes RD, Rasmussen KG.
    Neth J Med; 2006 Dec; 64(11):417-21. PubMed ID: 17179572
    [Abstract] [Full Text] [Related]

  • 16. Adjusting the frequency of continuation and maintenance electroconvulsive therapy to prevent relapse of catatonic schizophrenia in middle-aged and elderly patients who are relapse-prone.
    Suzuki K, Awata S, Takano T, Ebina Y, Shindo T, Harada N, Matsuoka H.
    Psychiatry Clin Neurosci; 2006 Aug; 60(4):486-92. PubMed ID: 16884452
    [Abstract] [Full Text] [Related]

  • 17. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Baghai TC, Marcuse A, Brosch M, Schüle C, Eser D, Nothdurfter C, Steng Y, Noack I, Pietschmann K, Möller HJ, Rupprecht R.
    World J Biol Psychiatry; 2006 Aug; 7(2):82-90. PubMed ID: 16684680
    [Abstract] [Full Text] [Related]

  • 18. Bifrontal versus bitemporal electroconvulsive therapy in severe manic patients.
    Barekatain M, Jahangard L, Haghighi M, Ranjkesh F.
    J ECT; 2008 Sep; 24(3):199-202. PubMed ID: 18772704
    [Abstract] [Full Text] [Related]

  • 19. Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature.
    Li TC, Shiah IS, Sun CJ, Tzang RF, Huang KC, Lee WK.
    J ECT; 2011 Jun; 27(2):165-7. PubMed ID: 21602639
    [Abstract] [Full Text] [Related]

  • 20. Repeated electroconvulsive therapy courses improved chronic regional pain with depression caused by failed back syndrome.
    Suzuki K, Ebina Y, Shindo T, Takano T, Awata S, Matsuoka H.
    Med Sci Monit; 2009 Apr; 15(4):CS77-9. PubMed ID: 19333208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.